Image

News & Events
Newsletter Sign-Up
Sign up here to receive notifications about upcoming events.
638436
July
20
12:00 PM

Hybrid Event: Two Novel Classes of Anticancer Compounds
This seminar will describe two novel classes of anticancer compounds derived from the nonsteroidal anti-inflammatory drug, sulindac. This drug is designed to lack cyclooxygenase inhibitory activity.